Discovery of novel regulators of the birth of blood platelets

October 7, 2013
Discovery of novel regulators of the birth of blood platelets
Credit: Shutterstock

EU research has led to a better understanding of the molecular mechanisms that make certain blood-producing cells function normally. The research will help prevent diseases that lead to heart attacks and strokes.

The work was done by researcher Marloes Tijssen, who was awarded a Marie Curie Intra-European Fellowship in 2010 for her project MEGAGEN ('Comparison of gene regulatory programs of blood stem and megakaryocytes').

Her work focused on 'megakaryocytes', the that produce blood 'thrombocytes' - the platelets that are necessary for normal blood clotting. Scientists believe that megakaryocytes are highly dependent on gene regulation for proper functioning.

"Increasing our knowledge of how these cells work to form platelets will contribute to the improvement of human health, as platelets are known to be major players in heart and blood vessel disease that can cause heart attacks and strokes," says Tijssen.

"In addition, patients with low counts, often induced by cancer treatment, currently receive platelets harvested from donors. With every transfusion, there is the risk of transmission of blood-borne infectious diseases. Therefore, ultimately, we would want to replace these donor-derived products with safer platelets produced in the laboratory."

Megakaryocytes, like all other types of , are derived from . These remain active throughout a person's lifetime, providing a constant supply of new blood cells. Cell identity and normal functioning are highly dependent on protein activity, which, in turn, depends on genes.

Serious problems, such as certain types of leukaemia, can arise when the tightly regulated phenomenon of gene translation is disturbed in blood cells.

Tijssen says that while sufficient numbers of megakaryocytes can be grown in the lab, efficient production of platelets from these cells is currently hampered by a lack of knowledge of the process of platelet formation.

Tijssen's work is of direct relevance to a number of other research groups focusing on the question of gene translation. Her discoveries are already playing a critical role in understanding platelet production. One of the genes identified in her project has been shown to decrease platelet count in living organisms.

"It is likely that among the key regulators of megakaryocyte growth uncovered by our work, there will be proteins or processes that can be modified to improve the production of platelets in the laboratory for transfusion into patients," she says.

Explore further: Mice with human immune cells help researchers discover how the mosquito-borne virus depletes blood platelets

More information: Project factsheet cordis.europa.eu/projects/rcn/93454_en.html

Related Stories

Mice with human immune cells help researchers discover how the mosquito-borne virus depletes blood platelets

October 3, 2013
Dengue fever, an infectious tropical disease found in more than 100 countries, has no cure and no vaccine. One reason why it has been difficult to develop new drugs for dengue fever is that there are no good animal models ...

New type of blood stem cell could help solve platelet shortage

August 13, 2013
Scientists funded by the Medical Research Council (MRC) have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets. The breakthrough may eventually ...

Researchers find key to blood-clotting process

June 26, 2013
Researchers, including Professor Alastair Poole and Dr Matthew Harper from the University of Bristol's School of Physiology and Pharmacology, have uncovered a key process in understanding how blood clots form that could help ...

Modeling of congenital amegakaryocytic thrombocytopenia using iPS cell technology

August 1, 2013
A research group led by researcher Shinji Hirata and Professor Koji Eto at CiRA has conducted a study in which iPS cells generated from a patient with congenital amegakaryocytic thrombocytopenia (CAMT) were induced to differentiate ...

Discovery helps explain why chemo causes drop in platelet numbers

September 25, 2011
Scientists at the Walter and Eliza Hall Institute have identified a way that chemotherapy causes platelet numbers to drop, answering in the process a decade-old question about the formation of platelets, tiny cells that allow ...

Recommended for you

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

New technique overcomes genetic cause of infertility

August 17, 2017
Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Inhibiting a protein found to reduce progression of Alzheimer's and ALS in mice

August 17, 2017
(Medical Xpress)—A team of researchers with Genetech Inc. and universities in Hamburg and San Francisco has found that inhibiting the creation of a protein leads to a reduction in the progression of Alzheimer's disease ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.